Meda Pharma GmbH & Co. KG

Clinical trials sponsored by Meda Pharma GmbH & Co. KG, explained in plain language.

Now part of Viatris Inc. VTRS NASDAQ

Pharmaceutical company specializing in branded and generic medicines.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

Bladder gel shows promise for chronic pelvic pain in women

Symptom relief Completed

This study tested a gel called Cystistat (sodium hyaluronate) placed directly into the bladder to treat women with interstitial cystitis, a condition causing long-term bladder pain. Researchers tracked 74 women to see if the gel improved their symptoms and was safe. The goal was …

Sponsor: MEDA Pharma GmbH & Co. KG • Aim: Symptom relief

Last updated Jun 27, 2026 08:09 UTC

Meda Pharma GmbH & Co. KG

Bladder gel shows promise for chronic pelvic pain in women